Groups Feed

The Surging Global Slit Lamp Breath Shield Market: Forecasting a Doubling to $1.0 Billion by 2035 Due to Heightened Infection Control Measures and Ophthalmic Safety Demands

The Global Slit Lamp Breath Shield Market is experiencing an explosive trajectory, expected to surge from a valuation of $436.7 million in 2024 to a monumental $1.0 billion by 2035, corresponding to an impressive Compound Annual Growth Rate (CAGR) of 7.8%. This remarkable growth is almost entirely propelled by a post-pandemic shift in global healthcare towards heightened infection control measures and the necessity of ensuring both patient and practitioner safety during routine eye examinations. The slit lamp breath shield, a critical piece of protective equipment, plays an essential role in mitigating the transmission of infectious diseases by containing aerosols. Market drivers include the increasing prevalence of eye disorders, which necessitates more frequent ophthalmic procedures, and a widespread awareness of the benefits of safety measures…

Global Orthopaedic Appliances Market Poised for Significant Growth to $60 Billion by 2035, Driven by Aging Populations and Advancements in 3D Printing and Bio-compatible Materials

The Global Orthopaedic Appliances Market is entering a period of robust expansion, projected to climb from a valuation of $40.6 billion in 2024 to an anticipated $60.0 billion by 2035, reflecting a steady Compound Annual Growth Rate (CAGR) of 3.6%. This growth is primarily fueled by the burgeoning global aging population, which is inherently susceptible to a higher incidence of musculoskeletal disorders like arthritis, and a rising occurrence of sports-related injuries across all demographics. The market is experiencing a fundamental shift driven by remarkable technological advancements, notably the integration of cutting-edge manufacturing techniques such as 3D printing and the use of sophisticated bio-compatible polymers. These innovations are crucial in facilitating the development of highly customized and patient-specific orthopedic solutions, moving away from generic, one-size-fits-all devices.…

Disaster Recovery as a Service Market: Safeguarding Business Continuity in a Cloud-Driven Era

In an increasingly digital and data-dependent world, business continuity has become a top priority for organizations of all sizes. The Disaster Recovery as a Service (DRaaS) market is emerging as a vital component of modern IT infrastructure, ensuring that businesses can recover swiftly from unexpected disruptions. DRaaS offers cloud-based backup, replication, and recovery solutions that minimize downtime, protect data integrity, and maintain operational resilience during natural disasters, cyberattacks, or system failures.

The global DRaaS market is experiencing rapid growth, driven by the accelerating adoption of cloud technologies and the growing need for cost-effective disaster recovery solutions. Traditional on-premise recovery systems often require significant capital investment and maintenance, which can be challenging for small and medium-sized enterprises (SMEs). In contrast, DRaaS operates on a subscription-based model, offering scalability, flexibility, and affordability. Businesses can customize recovery plans according to their…

The Global Ozone Therapy Unit Market: Exploring Growth Drivers, Therapeutic Applications in Chronic Disease and Pain Management, and Technological Innovations in Ozone Generation

The Ozone Therapy Unit Market is experiencing robust growth, primarily driven by the increasing acceptance and adoption of ozone gas as a complementary and alternative medical treatment. Ozone therapy instruments generate medical-grade ozone for therapeutic use, leveraging its antimicrobial, anti-inflammatory, and immunomodulatory properties to enhance health outcomes across a spectrum of conditions. The largest application segments are chronic disease management and pain management, where ozone therapy is utilized for conditions like arthritis, musculoskeletal disorders, and chronic wounds. The non-invasive nature and potential for reduced reliance on conventional pharmaceuticals are key factors driving patient and practitioner interest, particularly in regions like North America and Europe with established alternative therapy acceptance. The market scope includes ozone generators, insufflation devices, and various accessories, with the ozone generators segment being a…

Welcome to our group Mephitis Group! A space for us to connect and share with each other. Start by posting your thoughts, sharing media, or creating a poll.

Example of How a Non-Partisan Expert Testified & Renewed Hope

Dr Babarao's testimony, testimony, has certainly sent SHOCK waves round the Court and put the metaphorical cat amongst the pigeons from what I've seen by those reporting outside the MSM who are in attendance at this case. Even Judith Moritz has changed her reporting tone in tweets on 'X' (formerly Twitter) and, as for the rest of the MSM, they are either trying to disingenuously skim over it (the few/couple that I've seen giving the retrial a mention), totally ignore it/staying silent and nor giving much coverage (the majority?) or still trying to convince their readers/followers that Lucy Letby is the one that caused the harm with their usual derogatory headlines (the usual culprits, mainly the Daily Fail).

Reading about his testimony has certainly given me renewed hope and able to see that light at the end of a long…

The Colin Norris case is illustrative of the problems faced by the defence in relation to the lab test that identified the possibility of exogenous insulin administration.

There was a single lab result, in relation to a death, that revealed undetectable C-peptide with an insulin level of 12,408 pmol/L, combined with a blood sugar level of 0.6 mmol/L.

This was accepted by the jury as proof of exogenous insulin poisoning when combined with the evidence of the victim being in a coma before death, due to low blood sugar.

The test was clinical and could not be considered to meet forensic standards – no chain of custody for the sample and no repeat testing, for instance.

It was sufficient to convict.

It is possible that cases such as this convinced the defence that it was not possible to question the lab test.

The Stepping Hill Hospital case (Chua) is interesting.

The CPS originally blamed one nurse - then dropped the charge and blamed another, who was convicted.

But there was hard evidence, in that case, of tampering with IV bags and saline vials, which tested positive for insulin. The case then relied on staff rota and an alleged confession note.

There were two murder charges and 19 charges of harm through insulin.

Compare to the LL case.

No direct evidence of insulin in any TPN bags. Only two mixed cases put forward. There does not appear to be any discussion of how common hypogycemia is in neonates, or any attempt to rule out other causes of hypoglycemia. Theories were put forward as to how multiple TPN bags were spiked that contradicted other evidence. There does not appear to be a warning, by the judge, of the possibility of errors in lab testing,…

Further to my blog post on the subject, please post any comments here about organising a gathering on 25th April to support Lucy (or if preferred send an email to peter@chimpinvestor.com and I can post your comment/thoughts here on your behalf).